MCOLN2 and glioblastoma: Here, by Kaplan–Meier analysis, we found that high TRPML2 and loss of TRPML2 mRNA expression reduce the OS and are correlated with poor prognosis in GBM patients, whereas lower TRPML2 mRNA levels are associated with better OS and clinical outcome.